...
首页> 外文期刊>Apoptosis: An international journal on programmed cell death >Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G(2)/M arrest and cell survival in cells with p53 defects under heat stress
【24h】

Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G(2)/M arrest and cell survival in cells with p53 defects under heat stress

机译:检查点激酶2可分配用于调节p53响应,但是在热应激下的P53缺陷中的细胞中G(2)/ m的抑制和细胞存活是必需的

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hyperthermia induced by heat stress (HS) is known to inhibit proliferation and induce cell death in cancer. We previously demonstrated that checkpoint kinase 1 (Chk1) contributes to G(2)/M arrest and cell survival under HS; however, the role of Chk2, a functional analog of Chk1, in regulation of the cell cycle and cell death under HS is still unknown. Here, we addressed the role of Chk2 using Molt-4 cells with p53-targeted shRNA (Molt-4/shp53) and parental control cells (Molt-4/V). Chk2 inhibition suppressed C-terminal acetylation of p53 and delayed the induction of p53-target genes in Molt-4/V cells under HS; however, Chk2 inhibition failed to inhibit apoptosis induced by HS, indicating that Chk2 was dispensable for p53-dependent apoptosis under HS. In contrast, Chk2 inhibition abrogated G(2)/M arrest and promoted cell death induced by HS in HeLa cells and Molt-4/shp53 cells. Thus, we demonstrated for the first time that Chk2 was required for cell cycle arrest and cell survival, particularly in cells with p53 defects under HS. These findings indicated that Chk2 may be a selective target for p53-mutated or -deficient cancer treated with hyperthermia.
机译:已知通过热应激(HS)诱导的热疗抑制增殖并在癌症中诱导细胞死亡。我们之前证明了检查点激酶1(CHK1)有助于HS下的G(2)/ m骤停和细胞存活;然而,CHK2的作用是CHK1的功能性类似物,在HS下调节细胞周期和细胞死亡仍然未知。在这里,我们使用MOLT-4细胞使用P53靶向shRNA(Molt-4 / SHP53)和亲本控制细胞(Molt-4 / V)来解决CHK2的作用。 CHK2抑制抑制p53的C末端乙酰化,延迟HS下摩尔-4 / v细胞中p53-靶基因的诱导;然而,CHK2抑制未能抑制HS诱导的细胞凋亡,表明CHK2可分配P53依赖性细胞凋亡。相反,CHK2抑制废除G(2)/ M在HELA细胞和MOLT-4 / SHP53细胞中诱导的HS诱导的细胞死亡。因此,我们首次证明了CHK2需要用于细胞周期停滞和细胞存活,特别是在HS下具有p53缺陷的细胞中。这些发现表明,CHK2可以是用热疗治疗的p53-突变或癌症的选择性靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号